A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts.
Year: 2023
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ciara Marie Kelly, Viswatej Avutu, Ping Chi, Mark Andrew Dickson, Mrinal M. Gounder, Mary Louise Keohan, Sujana Movva, Evan Rosenbaum, Emma Cordover, Charlotte Eielson Ariyan, Edmund Bartlett, Aimee Marie Crago, Samuel Singer, Cristina R. Antonescu, Sinchun Hwang, Joseph Patrick Erinjeri, Kenneth Seier, Li-Xuan Qin, William D. Tap, Sandra P. D'Angelo
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4379345918